Category: Uncategorized

Posted on

CSX Corp. Announces Fourth Quarter and Full Year 2025 Results

JACKSONVILLE, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) today announced fourth quarter 2025 operating income of $1.11 billion and net earnings of $720 million, or $0.39 per share. Fourth quarter operating income and earnings per share include approximately $50 million and $0.02, respectively, in expenses related to severance and rationalization of specific technology investments. In the fourth quarter of 2024, the company reported operating income of $1.11 billion and net earnings of $733 million, or $0.38 per share. Excluding a pre-tax, non-cash goodwill impairment charge, adjusted operating income was $1.21 billion and adjusted net earnings were $815 million, or $0.42 per share, in the prior year quarter.1

“Our quarterly results reflect the subdued industrial demand environment and actions taken to adjust our cost structure,” said Steve Angel, president and chief executive officer. “CSX has a strong operational foundation, and we are positioned to deliver improved financial performance in 2026 as we focus on driving productivity, cost control, and capital discipline while continuing to provide safe and reliable service.”

Fourth Quarter Financia
l Highlights

1

  • Revenue totaled $3.51 billion for the quarter, decreasing 1% year-over-year, as the effects of lower merchandise volume and reduced export coal revenue offset higher pricing in merchandise and intermodal, an increase in intermodal volume, and higher fuel surcharge revenue.
  • Operating income was $1.11 billion, compared to adjusted operating income of $1.21 billion in the prior year. Operating margin was 31.6%, compared to operating margin of 31.3% and adjusted operating margin of 34.3% in the fourth quarter of 2024.
  • EPS was $0.39, compared to adjusted EPS of $0.42 in the prior year.
  • Fourth quarter operating income and EPS include $50 million and $0.02, respectively, in severance and technology rationalization expense.

Full Year 2025 Financia
l Highlights

1

  • Revenue totaled $14.09 billion in 2025.
  • Operating income was $4.52 billion, and adjusted operating income was $4.69 billion, excluding a $164 million goodwill impairment charge in the third quarter. CSX’s operating margin was 32.1% for the full year, and adjusted operating margin was 33.2%.
  • EPS was $1.54, and adjusted EPS was $1.61.

CSX executives will conduct a conference call with the investment community this afternoon, Jan. 22, at 4:30 p.m. Eastern Time. Investors, media and the public may listen to the conference call by dialing 1-888-510-2008. For callers outside the U.S., dial 1-646-960-0306. Participants should dial in 10 minutes prior to the call and enter 3368220 as the passcode.

In conjunction with the call, a live webcast will be accessible and presentation materials will be posted on the company’s website at http://investors.csx.com. Following the earnings call, a webcast replay of the presentation will be archived on the company website.

This earnings announcement, as well as additional detailed financial information, is contained in the CSX Quarterly Financial Report available through the company’s website at http://investors.csx.com and on Form 8-K with the Securities and Exchange Commission.

1See the Non-GAAP Measures section of the quarterly financial report for non-GAAP reconciliations and additional information.

About CSX and its Disclosures

CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural, and consumer products. For nearly 200 years, CSX has played a critical role in the nation’s economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation’s population resides. It also links more than 240 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike.

This announcement, as well as additional financial information, is available on the company’s website at http://investors.csx.com. CSX also uses social media channels to communicate information about the company. Although social media channels are not intended to be the primary method of disclosure for material information, it is possible that certain information CSX posts on social media could be deemed to be material. Therefore, we encourage investors, the media, and others interested in the company to review the information we post on X, formerly known as Twitter, (http://twitter.com/CSX) and on Facebook (http://www.facebook.com/OfficialCSX). The social media channels used by CSX may be updated from time to time. More information about CSX Corporation and its subsidiaries is available at www.csx.com.

Non-GAAP Disclosure

CSX reports its financial results in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). CSX also uses certain non-GAAP measures that fall within the meaning of Securities and Exchange Commission Regulation G and Regulation S-K Item 10(e), which may provide users of the financial information with additional meaningful comparison to prior reported results. Non-GAAP measures do not have standardized definitions and are not defined by U.S. GAAP. Therefore, CSX’s non-GAAP measures are unlikely to be comparable to similar measures presented by other companies. The presentation of these non-GAAP measures should not be considered in isolation from, as a substitute for, or as superior to the financial information presented in accordance with GAAP.

Forward-looking Statements

This information and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, margins, volumes, rates, cost-savings, expenses, taxes, liquidity, capital expenditures, dividends, share repurchases or other financial items, statements of management’s plans, strategies and objectives for future operations, and management’s expectations as to future performance and operations and the time by which objectives will be achieved, statements concerning proposed new services, and statements regarding future economic, industry or market conditions or performance. Forward-looking statements are typically identified by words or phrases such as “will,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” “preliminary” and similar expressions. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise any forward-looking statement. If the company updates any forward-looking statement, no inference should be drawn that the company will make additional updates with respect to that statement or any other forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties, and actual performance or results could differ materially from that anticipated by any forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by any forward-looking statements include, among others: (i) the company’s success in implementing its financial and operational initiatives; (ii) changes in domestic or international economic, political or business conditions, including those affecting the transportation industry (such as the impact of industry competition, conditions, performance and consolidation); (iii) legislative or regulatory changes; (iv) the inherent business risks associated with safety and security; (v) the outcome of claims and litigation involving or affecting the company; (vi) natural events such as severe weather conditions or pandemic health crises; and (vii) the inherent uncertainty associated with projecting economic and business conditions.

Other important assumptions and factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the company’s SEC reports, accessible on the SEC’s website at www.sec.gov and the company’s website at www.csx.com.

Contact:

Matthew Korn, CFA, Investor Relations
904-366-4515

Austin Staton, Corporate Communications
855-955-6397



Posted on

Pennsylvania American Water Asks Customers in 21 Counties to Reduce Nonessential Water Use During Drought Watch Declaration

PR Newswire

MECHANICSBURG, Pa., Jan. 20, 2026 /PRNewswire/ — Pennsylvania American Water is encouraging customers throughout portions of its statewide service territory to voluntarily reduce their water consumption in response to the drought watch declaration expansion announced recently by the Pennsylvania Department of Environmental Protection (DEP). While the company always encourages wise water use, Pennsylvania American Water is asking residents and businesses to voluntarily reduce their nonessential water use by 10-15% (a reduction of approximately 11-16 gallons per day) in accordance with DEP’s guidance.

“We’re asking our customers in affected areas to observe the DEP’s request and be mindful of their nonessential water use during this drought watch,” said Brandy Braun, director of water quality and environmental compliance for Pennsylvania American Water. “Our sources of supply are currently adequate to meet the needs of our customers, but we want to prepare for the potential for more severe conditions that could lead to stricter conservation measures in the future.” 

Of the 40 counties currently included in DEP’s drought watch declaration, 21 are within areas where Pennsylvania American Water provides water service. Those counties include Adams, Beaver, Berks, Butler, Chester, Clarion, Clearfield, Clinton, Cumberland, Indiana, Jefferson, Lackawanna, Lancaster, Lawrence, Lebanon, Monroe, Northampton, Pike, Schuylkill, Union and Washington.

Following a meeting of the Commonwealth Drought Task Force on Jan. 8, DEP expanded its existing 37-county drought watch declaration based on public water supply levels and data related to four indicators: precipitation, surface water flow, groundwater level and soil moisture. According to DEP, a drought watch declaration is the first and least severe level of the state’s three drought classifications. Learn more on DEP’s drought information webpage.

Pennsylvania American Water offers multiple water conservation resources in the Wise Water Use section of its website. It also is a member of the Alliance for Water Efficiency, which developed an online Water Use Calculator that allows visitors to input water use information specific to their household and offers tips on where they can save water and energy based on that data. The company also periodically shares water conservation tips and reminders with customers through email campaigns, bill enclosures and social media posts.

Below are tips for conserving water inside and outside the home: 

  • Run dishwashers and clothes washers only when they are full. If you have a water-saver cycle, use it.
  • Regularly check your toilet, faucets, and pipes for leaks with our free leak detection kits. If you find a leak, have it fixed as soon as possible.
  • Install water-saving showerheads, toilets and faucet aerators.
  • Consider water and energy-efficient appliances. Products and services that have earned the WaterSense label have been certified to be at least 20% more efficient while maintaining performance.
  • Turn off the tap while brushing your teeth or washing dishes in the sink.
  • Water your lawn only when it needs it. When you do, water in the early morning or evening to reduce evaporation.
  • Use a broom instead of a hose to clean your sidewalk, driveway or patio.
  • Set up a rain barrel to be ready to repurpose rain when it does fall. For information, see this Penn State Extension guide.

About American Water 
American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water’s 6,700 talented professionals leverage their significant expertise and the company’s national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.  

For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

About Pennsylvania American Water 

Pennsylvania American Water, a subsidiary of American Water, is the largest regulated water utility in the state with 1,200 dedicated employees working to provide safe, clean, reliable and affordable water and wastewater services to approximately 2.4 million people.  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pennsylvania-american-water-asks-customers-in-21-counties-to-reduce-nonessential-water-use-during-drought-watch-declaration-302665394.html

SOURCE American Water

Posted on

American Public Education, Inc. to Participate in The Oppenheimer 11th Annual Emerging Growth Conference

PR Newswire

CHARLES TOWN, W.Va., Jan. 20, 2026 /PRNewswire/ — American Public Education, Inc. (the “Company”) (Nasdaq: APEI), a company which transforms lives, advances careers and improves communities by providing online and campus-based postsecondary education to approximately 109,000 students, today announced that Angela Selden, President & Chief Executive Officer, Edward Codispoti, Chief Financial Officer, and Gary Janson, SVP Strategy & Growth will participate in the Oppenheimer 11th Annual Emerging Growth Conference, taking place virtually on Tuesday & Wednesday, February 3-4, 2026.

Management will be available for virtual one-on-one meetings with investors throughout both days. For conference details or to schedule a one-on-one meeting, please contact your Oppenheimer representative or investor relations at [email protected].

About American Public Education

American Public Education, Inc. (Nasdaq: APEI), through its institutions, American Public University System, or APUS, Rasmussen University, and Hondros College of Nursing, provides education that transforms lives, advances careers, and improves communities.

APUS, which operates through American Military University and American Public University, is the leading educator to active-duty military and veteran students* and serves approximately 88,700 adult learners worldwide via accessible and affordable higher education.

Rasmussen University is a 125-year-old nursing and health sciences-focused institution that serves approximately 15,900 students across its 20 campuses in six states and online. It also has schools of Business, Technology, Design, Early Childhood Education and Justice Studies.

Hondros College of Nursing focuses on educating pre-licensure nursing students at eight campuses (six in Ohio, one in Indiana, and one in Michigan). It is the largest educator of PN (LPN) nurses in the state of Ohio** and serves approximately 4,000 total students.

Both APUS and Rasmussen University are institutionally accredited by the Higher Learning Commission (HLC), an institutional accreditation agency recognized by the U.S. Department of Education. Hondros College of Nursing is accredited by the Accrediting Bureau of Health Education Schools (ABHES).    

*Based on FY 2023 Department of Defense tuition assistance data, as reported by Military Times, and Veterans Administration student enrollment data as of 2024.

**Based on information compiled by the National Council of State Boards of Nursing and Ohio Board of Nursing.

Company Contact
Frank Tutalo
Director, Public Relations
American Public Education, Inc.
[email protected]
571-358-3042

Investor Relations

Shannon Devine
MZ North America
Direct: 203-858-1945
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/american-public-education-inc-to-participate-in-the-oppenheimer-11th-annual-emerging-growth-conference-302664869.html

SOURCE American Public Education, Inc.

Posted on

ADP National Employment Report Preliminary Estimate December 27, 2025

PR Newswire

ROSELAND, N.J., Jan. 20, 2026 /PRNewswire/ — For the four weeks ending December 27, 2025, U.S. private employers added an average of 8,000 jobs per week, according to the NER Pulse, a weekly update of the monthly ADP National Employment Report (NER). 

The last week of 2025 showed a modest slowdown in hiring. These numbers are preliminary and could change as new data is added.

Week ending

Change

(Four-week moving
average, seasonally
adjusted)

12/27/2025

8,000

12/20/2025

11,250

12/13/2025

10,250

12/6/2025

8,750

11/29/2025

13,250

11/22/2025

3,750

11/15/2025

-8,500

11/8/2025

-11,750

11/1/2025

-7,500

10/25/2025

-4,750

10/18/2025

11,500

10/11/2025

10,250

The NER Pulse is an estimate of the week-over-week change in employment based on a four-week moving average. These estimates are based on ADP’s finely tuned, high-frequency data. The data are seasonally adjusted and have a two-week lag to allow for more complete and accurate estimates of real-time employment trends.

The NER Pulse, including 12 weeks of historical data, publishes every Tuesday at 8:15 a.m. ET, except weeks when ADP Research publishes the monthly National Employment Report which is built on a reference week that includes the 12th day of the month. The press release is available Tuesdays at 8:15 a.m. ET in the ADP Media Center. The NER Pulse is also available shortly after 8:15 a.m. ET on release days at ADP Research and in Main Street Macro.

The next NER Pulse will be released January 27, 2026. For upcoming release dates please refer to the calendar on the NER website.

The ADP National Employment Report and the NER Pulse are produced by ADP Research in collaboration with the Stanford Digital Economy Lab.

About ADP Research
The mission of ADP Research is to make the future of work more productive through data-driven discovery. Companies, workers, and policy makers rely on our finely tuned data and unique perspective to make informed decisions that impact workplaces around the world.

To subscribe to monthly email alerts or obtain additional information about ADP Research, including employment and pay data, methodology, and a calendar of release dates, please visit https://www.adpresearch.com.

About ADP (NASDAQ: ADP)
ADP has been shaping the world of work with innovation and expertise for more than 75 years. As a global leader in HR and payroll solutions, ADP continuously works to solve business challenges for our clients and their workers, from simple, easy-to-use tools for small businesses to fully integrated platforms for global enterprises – and everything in between. Always Designing for People means we’re focused on just that – people. We use our unmatched AI-driven insights and proven expertise to design innovative solutions that help people achieve greater success at work. More than 1.1 million clients across 140+ countries rely on ADP’s exceptional service to support their people and drive their business forward. HR, Talent, Time Management, Benefits, Compliance, and Payroll. Learn more at ADP.com.

ADP, the ADP logo, and Always Designing for People, ADP National Employment Report, and ADP Research are registered trademarks of ADP, Inc. All other marks are the property of their respective owners.

Copyright © 2026 ADP, Inc. All rights reserved.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/adp-national-employment-report-preliminary-estimate-december-27-2025-302664969.html

SOURCE ADP, Inc.

Posted on

ALT5 Sigma Corporation Restores Compliance with Nasdaq Periodic Filing Requirements

ALT5 Sigma Corporation Restores Compliance with Nasdaq Periodic Filing Requirements

LAS VEGAS–(BUSINESS WIRE)–ALT5 Sigma Corporation (the “Company” or “ALT5”) (NASDAQ: ALTS)(FRA: 5AR1) today announced that it received a notification letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”), indicating that it has regained compliance with the periodic filing requirements of The Nasdaq Stock Market under Listing Rule 5250(c)(1). As a result, Nasdaq has closed the matter, and the Company remains in good standing with respect to its Nasdaq filing listing requirements.

“We are pleased that this matter has been resolved and that the Company is once again back in compliance regarding its Financials late filing delinquency as per Nasdaq’s listing standards,” said Tony Isaac, President and CEO. “This filing represents our commitment to maintaining the highest standards of corporate governance and transparency. We take our regulatory obligations seriously, and we’re pleased to have completed this important milestone while delivering strong operational results for our stockholders.”

On November 19, 2025, the Company was notified by Nasdaq staff that it was not in compliance with the Rule due to the delayed filing of its periodic report. Following the January 12, 2026 filing of its Form 10-Q for the period ending September 27, 2025, Nasdaq staff determined that the Company now complies with the Rule again.

About ALT5 Sigma Corporation

ALT5 Sigma Corporation (NASDAQ: ALTS) (FRA:5AR1) is a fintech company with a strategic $WLFI digital asset treasury strategy initiative and established global payments, trading, and settlement infrastructure, including card-based programs supporting crypto-to-fiat and fiat-to-crypto transactions. Since the inception of the Company’s processing platforms in 2018, the Company has leveraged its blockchain infrastructure expertise and proven track record of processing over $8 billion in cryptocurrency transactions to optimize its digital asset treasury operations and capitalize on growing $WLFI ecosystem developments across retail platforms, payment integrations, and international market expansion.

Forward-looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to adoption of the $WLFI token, $WLFI’s potential initiatives, the positioning of the Company in the digital asset treasury sector, the availability of $WLFI for trading on crypto exchanges, the profitability and prospective growth of ALT5’s platforms and business that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5’s services, and technology challenges for future growth or expansion. This press release also contains general statements, including words such as “continue”, “expect”, “intend”, “will”, “hope”, “should”, “would”, “may”, “potential”, and other similar expressions. Such statements reflect the Company’s current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies. This press release, unlike other releases of the Company, does not contain statements regarding potential separation plans of the Company’s biotech business in respect of which the reader should review previous releases for forward-looking statements and previous filings with the SEC for specific risk factors related to such potential separation.

Many factors could cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, changes in the value of $WLFI tokens and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in the Company’s filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Media/Investor Relations

[email protected]

KEYWORDS: Nevada United States North America

INDUSTRY KEYWORDS: Professional Services Blockchain Technology Cryptocurrency Finance Fintech Digital Cash Management/Digital Assets

MEDIA:

Posted on

From Paddock to Penthouse Suite: World of Hyatt Brings Audi Revolut F1 Team Spirit to Luxury Hospitality

From Paddock to Penthouse Suite: World of Hyatt Brings Audi Revolut F1 Team Spirit to Luxury Hospitality

As the team’s official hospitality partner, World of Hyatt blends the innovation of Audi Revolut F1 Team with elevated hospitality to create unforgettable travel, cultural, and immersive experiences for members.

CHICAGO & HINWIL, Switzerland–(BUSINESS WIRE)–Hyatt Hotels Corporation (NYSE: H)today announced World of Hyatt will be the official hospitality partner of the new Audi Revolut F1 Team, uniting two global brands defined by a relentless pursuit of quality and experience. As the official hospitality partner of Audi Revolut F1 Team’s entrance into Formula 1, World of Hyatt will bring luxury travelers closer to the world of elite motorsport through an array of exclusive experiences and hospitality offerings.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114471636/en/

As the team's official hospitality partner, World of Hyatt blends the innovation of Audi Revolut F1 Team with elevated hospitality to create unforgettable travel, cultural, and immersive experiences for members.

As the team’s official hospitality partner, World of Hyatt blends the innovation of Audi Revolut F1 Team with elevated hospitality to create unforgettable travel, cultural, and immersive experiences for members.

World of Hyatt members can enjoy access to the sport’s most iconic moments. From behind-the-scenes paddock tours and driver meet-and-greets to private hospitality lounges and luxury weekend itineraries, members will have the opportunity to experience the world of Formula 1 like never before. In addition, members will be able to earn and redeem points for bespoke travel experiences surrounding key Grand Prix events, blending high performance with high style.

“World of Hyatt and the Audi Revolut F1 Team coming together allows us to take the excitement of the motorsport beyond the circuit and into unforgettable travel experiences for our members,” said Mark Hoplamazian, President and Chief Executive Officer, Hyatt. “With an unmatched global portfolio of hotels and resorts in many of the world’s most iconic Grand Prix destinations, we’re uniquely positioned to connect guests and members to the energy, creativity, and culture that surround races. We’re excited to bring this to life through curated experiences and special offerings that reflect the quality and innovation both brands are known for.”

“Hospitality plays a central role in Formula 1. With a truly global calendar, it is essential not only for how we welcome partners, guests and fans, but also for how we support our own team as it travels continuously throughout the season,” said Stefano Battiston, Chief Commercial Officer of Audi Revolut F1 Team. “World of Hyatt’s entry into Formula 1 comes at a natural moment in our own journey as a new team, and this brings together two brands with a shared focus on quality, experience and long-term thinking. Together with World of Hyatt, we will take the Formula 1 experience beyond the racetrack, creating elevated, behind-the-scenes moments that bring fans closer to Audi Revolut F1 Team in new and meaningful ways.”

As Hyatt advances their rapid global expansion, this relationship with Audi Revolut F1 Team highlights their mutual momentum and reinforces a collective commitment to shaping exceptional experiences and driving growth in strategic international markets. By merging culture, sport, and design at a global scale, Hyatt properties worldwide will reflect the elegance and dynamism of Formula 1 through curated events and limited-edition offerings inspired by race weekends. Coming soon, guests can expect an evolving slate of immersive programs and bespoke touchpoints that further bring this to life by ushering in a new era of innovation and elevated guest experiences across participating Hyatt hotels.

The term “Hyatt” is used in this release to refer to Hyatt Hotels Corporation and/or one or more of its affiliates.

For further information:

About World of Hyatt

World of Hyatt is Hyatt’s award-winning guest loyalty program uniting participating locations in Hyatt’s Luxury Portfolio, including Park Hyatt®, Alila®, Miraval®, Impression by Secrets, and The Unbound Collection by Hyatt®; the Lifestyle Portfolio, including Andaz®, Thompson Hotels®, The Standard®, Dream® Hotels, The StandardX, Breathless Resorts & Spas®, JdV by Hyatt®, Bunkhouse® Hotels, and Me and All Hotels; the Inclusive Collection, including Zoëtry® Wellness & Spa Resorts, Hyatt Ziva®, Hyatt Zilara®, Secrets® Resorts & Spas, Dreams® Resorts & Spas, Hyatt Vivid Hotels & Resorts, Sunscape® Resorts & Spas, and Alua Hotels & Resorts®; the Classics Portfolio, including Grand Hyatt®, Hyatt Regency®, Destination by Hyatt®, Hyatt Centric®, Hyatt Vacation Club®, and Hyatt®; and the Essentials Portfolio, including Caption by Hyatt®, Hyatt Place®, Hyatt House®, Hyatt Studios, and UrCove. Members who book directly through Hyatt channels can enjoy personalized care and access to distinct benefits including Guest of Honor, confirmed suite upgrades at time of booking, diverse wellbeing offerings, digital key, and exclusive member rates. With 61 million members and counting, World of Hyatt offers a variety of ways to earn and redeem points for hotel stays, dining and spa services, wellbeing focused experiences through the FIND platform; as well as the benefits of Hyatt’s strategic loyalty collaboration with American Airlines AAdvantage®. Travelers can enroll for free at hyatt.com, download the World of Hyatt app for android and IOS devices and connect with World of Hyatt on Facebook, Instagram, TikTok and X.

About Audi Revolut F1 Team

Audi Revolut F1 Team is the official factory team of Audi, as the brand enters the FIA Formula 1 World Championship for the first time in 2026. This project, in which Audi will create its own hybrid drive system (‘power unit’) developed in Germany, represents the ultimate expression of the manufacturer’s ‘Vorsprung durch Technik’ philosophy and embodies a long-term commitment to compete at the pinnacle of motorsport with the clear objective of challenging for world championships by 2030. Audi Revolut F1 Team is based in three locations: the power unit is developed by Audi Formula Racing GmbH at the Audi Competence Center Motorsport in Neuburg, Germany; the chassis is engineered and race operations are managed from the state-of-the-art facilities of Audi Motorsport AG in Hinwil, Switzerland; while the Audi Motorsport Technology Centre UK in Bicester, United Kingdom, provides a foothold in the heart of ‘Motorsport Valley’, with direct access to top F1 talent and key strategic partners. This integrated structure provides complete control over the project, embedding a culture of precision, innovation, and relentless performance. Audi’s entry is strategically timed to coincide with new Formula 1 regulations focused on increased electrification, as the electric share of the hybrid drive is raised to almost 50%, and the introduction of 100% sustainable fuels. The entry into Formula 1, one of the most important platforms in the world, serves as a high-tech catalyst for the entire Audi brand, acting as a global stage to demonstrate technological leadership and connect with new, diverse audiences by creating cultural impact that resonates far beyond the race track.

Media Contacts:

Hyatt

Emily Mekstan

[email protected]

Audi Revolut F1 Team

Vanessa Roettger

Brand Communications, Audi Revolut F1 Team

+41 79 75 75 285

[email protected]

www.audif1.com

KEYWORDS: Illinois Europe Switzerland United States North America

INDUSTRY KEYWORDS: Other Travel Lodging EV/Electric Vehicles Travel Automotive Vacation Other Automotive Performance & Special Interest

MEDIA:

Photo
Photo
As the team’s official hospitality partner, World of Hyatt blends the innovation of Audi Revolut F1 Team with elevated hospitality to create unforgettable travel, cultural, and immersive experiences for members.
Photo
Photo
Logo
Logo
Posted on

National Fuel Schedules First Quarter Fiscal 2026 Earnings Conference Call

WILLIAMSVILLE, N.Y., Jan. 13, 2026 (GLOBE NEWSWIRE) — National Fuel Gas Company (NYSE: NFG) today announced it will release its first quarter fiscal 2026 earnings results on Wednesday, January 28, 2026 after market close.

A conference call to discuss the results will be held on Thursday, January 29, 2026 beginning at 9:00 a.m. ET and will include prepared remarks from the executive team followed by a question and answer session.

All participants must pre-register to join this conference using the Participant Registration link.

A webcast link to the conference call will be provided under the Events Calendar on the NFG Investor Relations website at investor.nationalfuelgas.com.

A replay will be available following the call through the end of the day, Thursday, February 5, 2026. To access the replay, dial 1-866-813-9403 and provide Access Code 870164.

For additional information, contact:

Natalie Fischer, Director of Investor Relations (716) 857-7315
Kathryn Nikisch-Hoffman, Lead Equity Plan Administrator (716) 857-7340
Karen Merkel, Media Contact (716) 857-7654
Email: [email protected]

National Fuel is an integrated energy company reporting financial results for three operating segments: Integrated Upstream and Gathering, Pipeline and Storage, and Utility. Additional information about National Fuel is available at www.nationalfuel.com.



Posted on

Saie Named an Official Partner of the New York Knicks

Saie Named an Official Partner of the New York Knicks

Saie will be Integrated Throughout Knicks Games at The Garden, Including Brand Exposure and Unique Activations

NEW YORK–(BUSINESS WIRE)–
Madison Square Garden Sports Corp. (NYSE: MSGS) announced today a brand-new partnership with Saie, a clean beauty brand that focuses on high-performance formulas and sustainable packaging, naming the brand an Official Partner of the New York Knicks.

With this partnership, Saie will receive brand exposure in Madison Square Garden through in-arena LED signage and GardenVision features during Knicks regular season home games. Saie will be featured on the 7th Avenue LED Marquee sign, making the brand visible to the millions of people who walk by The Garden every day.

“The Knicks are always looking for new ways to grow and strengthen our fanbase, including expanding the reach of our marketing partnerships,” said Doug Jossem, Executive Vice President Global Sports and Entertainment Partnerships, MSG Entertainment. “We are excited to launch this relationship with Saie and look forward to connecting with new audiences through this partnership.”

“Saie has always been shaped by the energy of New York, and partnering with the Knicks feels so full circle,” said Laney Crowell, CEO & Founder of Saie. “The grit and performance of the Knicks represent the same qualities that inspire us to create long lasting, high performing products like our newest 16-hour setting spray CitySet. We’re so excited to expand our community and be part of such an iconic cultural moment in the city that built us.”

Additionally, Saie will appear on the Knicks website as part of rotating banner advertisements further amplifying the brand’s presence.

About Madison Square Garden Sports Corp.

Madison Square Garden Sports Corp. (MSG Sports) is a leading professional sports company, with a collection of assets that includes the New York Knicks (NBA) and the New York Rangers (NHL), as well as two development league teams – the Westchester Knicks (NBAGL) and the Hartford Wolf Pack (AHL). MSG Sports also operates a professional sports team performance center – the MSG Training Center in Greenburgh, NY. More information is available at msgsports.com.

About Saie

Saie is a clean, performance-driven makeup brand with a mission to feel good and do good, for people and the planet. Founded in 2019 by beauty industry veteran, Laney Crowell, Saie set a new industry standard with high-performance formulas, sustainable packaging and practices, and a promise to create positive change. Saie’s name comes from its highly engaged community: When they say it, Saie creates it. Saie’s award-winning products are elevated, effortless, and easy to use – best known for their signature lilac packaging, skincare properties and the trademarked SaieGlow™ . Formulated using only the purest, safest ingredients, Saie omits over 2,000 harmful ingredients and is proud to hold Climate Neutral and Leaping Bunny certifications. Available at Sephora stores nationwide and saiehello.com.

MEDIA CONTACTS:

Madison Square Garden Sports:

[email protected]

Saie:

Desiree Kaplowitz

Vice President, Public Relations

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Basketball Sports Entertainment Marketing Advertising Communications Events/Concerts Digital Marketing Cosmetics Retail

MEDIA:

Logo
Logo
Posted on

Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC

Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC

Significant Unmet Need Remains in this Setting

Over 14,000 Patients are Eligible for 2L+ Treatment in This Setting in the United States Each Year

Summit Enters 2026 with Approximately $710 Million in Cash

MIAMI–(BUSINESS WIRE)–
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for ivonescimab, the novel, first-in-class investigational bispecific antibody, in combination with chemotherapy in second-line or later treatment of patients with epidermal growth factor receptor (EGFR)-mutated locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC). The BLA submission was based on the overall results of the global Phase III HARMONi trial. The BLA was submitted during the fourth quarter of 2025.

“This BLA submission, the first for ivonescimab, marks a critical milestone for Summit, our global clinical development plan, and the many patients with EGFRm NSCLC in need of better therapeutics options,” stated Robert W. Duggan and Dr. Maky Zanganeh, Co-Chief Executive Officers of Summit. “As we continue to support and expand ivonescimab’s rapid development via our growing set of global Phase III trials and clinical collaborations, we look forward to the potential first U.S. approval for ivonescimab in this difficult to treat setting.”

HARMONi evaluated ivonescimab plus platinum-doublet chemotherapy compared to placebo plus platinum-doublet chemotherapy in patients with EGFR-mutated, locally advanced or metastatic NSCLC who have progressed after treatment with a 3rd generation EGFR tyrosine kinase inhibitor (TKI). This is a clinical setting with a patient population where PD-1 monoclonal antibodies have previously been unsuccessful in Phase III global clinical trials in showing either a progression-free survival (PFS) or overall survival (OS) benefit, the two primary endpoints of this clinical study.

Based upon standard review timelines, if the application is accepted as submitted, we anticipate a decision from the agency by the fourth quarter of 2026.

Update Regarding Current Financial Position

As of December 31, 2025, the company’s preliminary unaudited balance of cash, cash equivalents, and short-term investments was approximately $710 million. This amount is preliminary and is subject to completion of financial closing procedures. As a result, this amount may differ from the amount that will be reflected in the Company’s consolidated financial statements for the year ended December 31, 2025.

About Ivonescimab

Ivonescimab, known as SMT112 in Summit’s license territories, North America, South America, Europe, the Middle East, Africa, and Japan, and as AK112 outside of Summit’s license territories, is a novel, potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. By design, ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity to PD-1 when in the presence of VEGF.

This is intended to differentiate ivonescimab as there is potentially higher expression (presence) of both PD-1 and VEGF in tumor tissue and the tumor microenvironment (TME) as compared to normal tissue in the body. We believe ivonescimab’s specifically engineered tetravalent structure (four binding sites) enables higher avidity (accumulated strength of multiple binding interactions) in the TME (Zhong, et al, SITC, 2023). This tetravalent structure, the intentional novel design of the molecule, and bringing these two targets into a single bispecific antibody with cooperative binding qualities have the potential to direct ivonescimab to the tumor tissue versus healthy tissue. The intent of this design, together with a half-life of 6 to 7 days after the first dose (Zhong, et al, SITC, 2023) increasing to approximately 10 days at steady state dosing, is to improve upon previously established efficacy thresholds, side effects, and safety profiles associated with prior approved drugs to these targets.

Ivonescimab was engineered by Akeso Inc. (HKEX Code: 9926.HK) and is currently utilized in multiple Phase III clinical trials. Over 4,000 patients have been treated with ivonescimab in clinical studies globally, and over 60,000 patients when considering those treated in a commercial setting in China, as noted by Akeso.

Summit began its clinical development of ivonescimab in NSCLC, commencing enrollment in 2023 in two multiregional Phase III clinical trials, HARMONi and HARMONi-3. In 2025, the Company began enrolling patients in HARMONi-7. Summit expanded its Phase III clinical development program into CRC in the fourth quarter of 2025 by initiating enrollment in HARMONi-GI3.

HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI (e.g., osimertinib). Detailed results of the study were provided in September 2025, and a Biologics License Application (BLA) was submitted to the United States Food and Drug Administration (FDA) for marketing authorization in the fourth quarter of 2025.

HARMONi-3 is a Phase III clinical trial, which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic, squamous or non-squamous NSCLC, irrespective of PD-L1 expression.

HARMONi-7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression.

HARMONi-GI3 is a Phase III clinical trial evaluating ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy in patients with first-line unresectable metastatic CRC.

In addition, Akeso has recently had positive read-outs in three single-region (China), randomized Phase III clinical trials, HARMONi-A, HARMONi-2, and HARMONi-6, for ivonescimab in NSCLC, including a statistically significant overall survival benefit in HARMONi-A with a manageable safety profile in each study.

HARMONi-A was a Phase III clinical trial which evaluated ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with an EGFR TKI.

HARMONi-2 is a Phase III clinical trial evaluating monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic NSCLC whose tumors have positive PD-L1 expression.

HARMONi-6 is a Phase III clinical trial evaluating ivonescimab in combination with platinum-based chemotherapy compared with tislelizumab, an anti-PD-1 antibody, in combination with platinum-based chemotherapy in patients with locally advanced or metastatic squamous NSCLC, irrespective of PD-L1 expression.

Akeso is actively conducting multiple Phase III clinical studies in settings outside of NSCLC, including biliary tract cancer, colorectal cancer, breast cancer, pancreatic cancer, small cell lung cancer, and head and neck cancer.

Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was initially approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.

About Summit Therapeutics

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol “SMMT”). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.

For more information, please visit https://www.smmttx.com and follow us on X @SMMT_TX.

Summit Forward-looking Statements

Any statements in this press release about the Company’s future expectations, plans and prospects, including but not limited to, statements about the clinical and preclinical development of the Company’s product candidates, entry into and actions related to the Company’s partnership with Akeso Inc., the intended use of the net proceeds from the private placements, the Company’s anticipated spending and cash runway, the therapeutic potential of the Company’s product candidates, the potential commercialization of the Company’s product candidates, the timing of initiation, completion and availability of data from clinical trials, the potential submission of applications for marketing approvals, the expected timing of BLA submissions or FDA decisions, potential acquisitions, statements about the previously disclosed At-The-Market equity offering program (“ATM Program”), the expected proceeds and uses thereof, the Company’s estimates regarding stock-based compensation, and other statements containing the words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “would,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the Company’s ability to sell shares of our common stock under the ATM Program, the conditions affecting the capital markets, general economic, industry, or political conditions, including the effects of geopolitical developments, domestic and foreign trade policies, and monetary policies, the results of our evaluation of the underlying data in connection with the development and commercialization activities for ivonescimab, the outcome of discussions with regulatory authorities, including the Food and Drug Administration, the uncertainties inherent in the initiation of future clinical trials, availability and timing of data from ongoing and future clinical trials, the results of such trials, and their success, global public health crises, that may affect timing and status of our clinical trials and operations, whether preliminary results from a clinical trial will be predictive of the final results of that trial or whether results of early clinical trials or preclinical studies will be indicative of the results of later clinical trials, whether business development opportunities to expand the Company’s pipeline of drug candidates, including without limitation, through potential acquisitions of, and/or collaborations with, other entities occur, expectations for regulatory approvals, laws and regulations affecting government contracts and funding awards, availability of funding sufficient for the Company’s foreseeable and unforeseeable operating expenses and capital expenditure requirements and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of filings that the Company makes with the Securities and Exchange Commission. Summit defines a “positive study” as a clinical study that with one or more prespecified primary endpoints in which one of those endpoints achieves a statistically significant benefit according to the protocol or statistical analysis plan. Any change to our ongoing trials could cause delays, affect our future expenses, and add uncertainty to our commercialization efforts, as well as to affect the likelihood of the successful completion of clinical development of ivonescimab. Accordingly, readers should not place undue reliance on forward-looking statements or information. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of this release and should not be relied upon as representing the Company’s views as of any subsequent date. The Company specifically disclaims any obligation to update any forward-looking statements included in this press release.

Summit Therapeutics and the Summit Therapeutics logo are trademarks of Summit Therapeutics Inc. and/or its affiliates

Copyright 2026, Summit Therapeutics Inc. All Rights Reserved

Contact Summit Investor Relations:

Dave Gancarz

Chief Business & Strategy Officer

Nathan LiaBraaten

Senior Director, Investor Relations

[email protected]

[email protected]

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Research Medical Devices FDA Clinical Trials Health Technology Biotechnology Pharmaceutical Health Science Oncology

MEDIA:

Logo
Logo
Posted on

QXO Upsizes Convertible Preferred Equity Placement to $3 Billion

QXO Upsizes Convertible Preferred Equity Placement to $3 Billion

Apollo and Temasek Lead Expanded Capital Commitment to Fund Future Acquisitions

GREENWICH, Conn.–(BUSINESS WIRE)–
QXO, Inc. (NYSE: QXO) (the “Company” or “QXO”) today announced a $1.8 billion increase to its previously announced $1.2 billion financing led by funds managed by affiliates of Apollo Global Management, Inc. (NYSE: APO) (“Apollo”), bringing the total investment in QXO to $3 billion. Apollo, Temasek, and certain other investors have agreed to make the investment through the previously disclosed series of convertible perpetual preferred stock (the “Series C Preferred Stock”). The investment further strengthens QXO’s financial flexibility to pursue strategic acquisition opportunities.

Under the investment agreement, the investors have committed to purchase Series C Preferred Stock to fund one or more qualifying acquisitions through July 15, 2026. This commitment will be extended for up to an additional 12 months if a definitive acquisition agreement is executed before the initial commitment period expires. Any issuance of the Series C Preferred Stock will close at or around the closing of the qualifying acquisition(s).

The offer and sale of the foregoing securities are being made in a transaction not involving a public offering. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be reoffered or resold in the United States except through an effective registration statement or an applicable exemption from the registration requirements. The Company has agreed to use commercially reasonable efforts to file a prospectus supplement with the Securities and Exchange Commission (“SEC”) to register the resale of the Series C Preferred Stock and underlying common stock issuable upon conversion.

This press release is issued pursuant to Rule 135c under the Securities Act and does not constitute an offer to sell or a solicitation of an offer to buy any securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About QXO

QXO is the largest publicly traded distributor of roofing, waterproofing, and complementary building products in North America. The company plans to become the tech-enabled leader in the $800 billion building products distribution industry and generate outsized value for shareholders. QXO is targeting $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth. Visit QXO.com for more information.

About Apollo

Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of September 30, 2025, Apollo had approximately $908 billion of assets under management. To learn more, please visit www.apollo.com.

About Temasek

Temasek is a global investment company headquartered in Singapore, with a net portfolio value of S$434 billion (US$324 billion) as at 31 March 2025. Its Purpose “So Every Generation Prospers” guides it to make a difference for today’s and future generations. Temasek seeks to build a resilient and forward-looking portfolio that will deliver sustainable returns over the long term. It has 13 offices in 9 countries around the world: Beijing, Hanoi, Mumbai, Shanghai, Shenzhen, and Singapore in Asia; and Brussels, London, Mexico City, New York, Paris, San Francisco, and Washington, DC outside Asia. For more information on Temasek, please visit www.temasek.com.sg.

Forward-looking statements

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact, including statements with respect to the issuance of the Series C Preferred Stock and the terms thereof, are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “trajectory” or the negative of these terms or other comparable terms. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances.

These forward-looking statements are subject to known and unknown risks, uncertainties, and assumptions that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause or contribute to a material difference include the risks discussed in our filings with the SEC, and the following:

  • an inability to obtain the products we distribute, resulting in lost revenues and reduced margins and damaging our relationships with customers;

  • a change in supplier pricing and demand, which may adversely affect our income and gross margins;

  • a change in vendor rebates, which may adversely affect our income and gross margins;

  • our inability to identify potential acquisition targets or successfully complete acquisitions on acceptable terms;

  • risks related to maintaining our safety record;

  • the possibility that building products distribution industry demand may soften or shift substantially due to cyclicality or dependence on general economic and political conditions, including inflation or deflation, interest rates, governmental subsidies or incentives, consumer confidence, labor and supply shortages, weather and commodity prices;

  • the possibility that regional, national or global barriers to trade, including trade wars, could increase the cost of products in the building products distribution industry, which could adversely impact the competitiveness of such products and the financial results of businesses in the industry;

  • seasonality, weather-related conditions and natural disasters;

  • risks related to the proper functioning of our information technology systems, including threats related to cybersecurity and artificial intelligence;

  • loss of key talent or our inability to attract and retain new qualified talent;

  • risks related to work stoppages, union negotiations, labor disputes and other matters associated with our labor force or the labor forces of our suppliers or customers;

  • the risk that the anticipated benefits of our acquisition of Beacon Roofing Supply, Inc. (the “Beacon Acquisition”) or any future acquisition may not be fully realized or may take longer to realize than expected;

  • the effect of the Beacon Acquisition or any future acquisition on our business relationships with employees, customers or suppliers, operating results and the business generally;

  • unexpected liabilities, costs, charges, expenses or accounting adjustments resulting from the Beacon Acquisition or any future acquisition or difficulties in integrating and operating acquired companies;

  • risks related to the Company’s obligations under the indebtedness incurred in connection with the Beacon Acquisition;

  • the risk that the Company is or becomes highly dependent on the continued leadership of Brad Jacobs as chairman and chief executive officer and the possibility that the loss of Mr. Jacobs in these roles could have a material adverse effect on the Company’s business, financial condition and results of operations;

  • the possible economic impact of the Company’s outstanding warrants and preferred stock on the Company and the holders of its common stock, including market price volatility, dilution from the exercise or conversion of the warrants or preferred stock, or the impact of dividend payments from preferred stock that remains outstanding;

  • challenges in raising additional equity or debt capital from public or private markets to pursue the Company’s business plan and the effects that raising such capital may have on the Company and its business;

  • the possibility that new investors in any future financing transactions could gain rights, preferences and privileges senior to those of the Company’s existing stockholders;

  • risks associated with periodic litigation, regulatory proceedings and enforcement actions, which may adversely affect the Company’s business and financial performance;

  • the impact of legislative, regulatory, economic, competitive and technological changes;

  • unknown liabilities and uncertainties regarding general economic, business, competitive, legal, regulatory, tax and geopolitical conditions; and

  • other factors, including those set forth in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q.

All forward-looking statements set forth in this release are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences for or effects on us or our business or operations. Forward-looking statements set forth in this release speak only as of the date hereof, and we do not undertake any obligation to update forward-looking statements except to the extent required by law.

QXO Contacts:

Media

Joe Checkler

[email protected]

203-609-9650

Investors

Mark Manduca

[email protected]

203-321-3889

Apollo Contacts:

Media

Joanna Rose

[email protected]

212-822-0491

Investors

Noah Gunn

[email protected]

212-822-0540

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Building Systems Commercial Building & Real Estate Construction & Property Finance Professional Services Trucking Asset Management Transport Urban Planning REIT Interior Design Logistics/Supply Chain Management Architecture Other Construction & Property

MEDIA:

Logo
Logo